Organogenesis Holdings Inc. announced revenue guidance for the fourth quarter and year ended December 31, 2018 and the year ended December 31, 2019. The company expects to report net revenue for the fourth quarter of between $62.1 million and $63.1 million, resulting in expected net revenue for the year ended December 31, 2018 of between $192 million and $193 million. In addition, the company announced total net revenue expectations for the year ended December 31, 2019. For the fiscal 2019 period, the company expects total net revenue of between $248 million and $259 million, representing growth of approximately 29% to 35% year-over-year as compared to the midpoint of the expected 2018 results of approximately $192.5 million.